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Abstract 
Nervous system injuries associated with epidemic hemorrhagic fever (EHF) are not rarely 
seen. However, cerebrovascular disease arising from EHF is rarely reported in the literature. 
A 50-year-old male patient suffered from subarachnoid hemorrhage (SAH). No abnormal 
condition was found in intracranial vascular digital subtraction angiography (DSA). But, this 
patient presented with positive hantavirus-IgM and IgG, with typical clinical process, which 
lead to the diagnosis of EHF followed by SAH. To our knowledge, SAH associated with EHF 
has not been previously reported. A meticulous assessment of EHF patients with a serious 
condition had one or more central nervous system (CNS) abnormalities, such as sudden 
headache, vomiting, confusion, meningismus, and convulsions, which is necessary for diag-
nosing and giving timely treatment to improve the prognosis. 
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Introduction 
The nervous system injuries associated with ep-
idemic hemorrhagic fever (EHF) are not rarely seen, 
such as nervous system infection, hypophysis func-
tion  decline,  epilepsy,  peripheral  neuropathy,  cere-
brovascular disease and so on1,2,3,4,5. However, cere-
brovascular  disease  arising  from  EHF  is  rarely  re-
ported. Cases presented in the literature are of cere-
bral lobe hemorrhage and cerebral infarction caused 
by EHF6. Here, we reported a rare case of subarach-
noid hemorrhage (SAH) which was associated with 
EHF. 
Case Report 
In  October  2008,  a  50-year-old  man  presented 
with progressive fever, headache, nausea and vomit-
ing for five days. On physical examination, the tem-
perature  was  39  ℃,  blood  pressure  (BP)  was  86/60 
mm Hg, bulbar conjunctiva was congestive. But his 
neurological system and other systemic examinations 
were  unremarkable.  His  white  blood  cell  was 
23×109/L,  haemoglobin  was  166g/L,  blood  platelet 
was  79×109/L,  urea  was  16.85  mmol/L,  creatinine 
was 291 umol/L and uric acid was 496 umol/L. The 
results of prothrombin time (PT), activate part blood 
coagulation  time  (APTT),  thrombin  time  (TT)  and 
fibrinogen (FIG) were in normal range. Both hepatitis 
B and C virus test were negative. Cerebral computed 
tomography (CT) scan was normal (Fig. 1). The elec-
troencephalogram  showed  slight  abnormality,  and 
both  intracranial  pressure  and  cerebrospinal  fluid 
were normal. The patient was diagnosed and treated 
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as viral encephalitis. However, seven days later, his 
headache became more and more serious and the se-
cond cerebral CT presented SAH (Fig. 2), but there 
was no remarkable finding on neurological examina-
tion. The next day, he presented neck rigidity. There-
fore,  intracranial  vascular  digital  subtraction  angi-
ography (DSA) was carried out to find out the cause 
of SAH. However, the result of DSA was unremarka-
ble (Fig. 3A and B). In order to find out the pathogen, 
we  consulted  a  doctor  for  infectious  diseases;  she 
considered it to be EHF and suggested us to detect the 
serum  antibody  EHF-IgM  and  EHF-IgG,  and  both 
results were positive by indirect immunofluorescence 
in our central laboratory.  
 
 
 
 
Figure 1: Non-anomalous findings of head CT. 
 
 
 
Figure 2: Diffused high-density video in the bilateral sub-
arachnoid space on repeat head CT seven days later. 
 
 
 
 
Figure 3: DSA showed unremarkable in the bilateral in-
ternal carotid artery (ICA) (A: right, B: left) 
 
 
There is a high incidence of EHF by hantavirus in 
Chinese zunyi, which is a mountainous district. The 
popular season in zunyi is unimodal, which means a 
popular peak from October to next January7. Accord-
ing to the state of illness, its epidemiology features, 
and the positive laboratory examination results, this 
patient  was  diagnosed  as  EHF  clearly.  Therefore, 
ribavirin  was  given  as  antiviral  treatment,  and 
symptomatic and supportive treatment are available, 
such  as  absolute  bed  rest,  mannitol  dehydration, 
etamsylate  stanching,  correcting  ion  disorders,  etc. 
One month later, he recovered well. 
Discussion 
EHF caused by hantavirus is a severe systemic 
infection, with acute shock, vascular leakage, hypo-
tension, and acute renal failure. Its clinical courses are 
divided into five phases: febrile, hypotensive, oligu-
ric,  diuretic  and  convalescent1,2,8.  Hantavirus  EHF Int. J. Med. Sci. 2011, 8 
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with renal syndrome could be found in most region of 
China. Another haemorrhagic fever caused by dengue 
virus  with  renal  syndrome  is  found  mainly  in  the 
south of China9. Cases of the performance of nervous 
system damage after EHF were sporadically reported. 
And this case was to report, for the first time, the SAH 
associated  with  the  EHF.  As  is  known  to  all,  the 
causes of SAH are intracranial aneurysm and intra-
cranial vascular malformations or agenesis10,11. Clini-
cally,  patients  with  suspected  SAH  could  be  diag-
nosed by the head CT or lumbar puncture, and DSA is 
the most effective way to find out the causes of SAH. 
But there is no abnormal condition in the DSA in our 
patient.  Diagnosis  of  EHF  is  mainly  based  on  the 
smptoms and a history of exposure to the endemic 
focus area where Zunyi is an epidemic area of EHF. 
Moreover, this patient presented with positive hanta-
virus-IgM and IgG, and his clinical process was rep-
resentative.  The  whole  appearance  is  like  EHF  fol-
lowed by SAH, although the familiar bleeding part of 
EHF is not in the subarachnoid space2. 
With  the  pathogenesis  of  EHF  and  patient  in-
formation, the causes of SAH may be associated with 
the following factors. On the one hand, the balance of 
blood  coagulation  and  fibrinolysis  is  lost  from  the 
early stage of EHF, TT and PT are prolonged, FIG, 
antithrombin-III (AT-III) and plasminogen (PLG) are 
decreased  and  fibrin-fibrinogen  degraded  products 
(FDP)  is  increased.  Besides,  the  decrease  of  platelet 
count,  the  platelet  functions  of  aggregation  and  re-
lease are below the normal level12. On the other hand, 
the virus can induce the production of immune com-
plexes  and  cytokines,  which  can  damage  the  brain 
small blood vessels13. In addition, prior to the onset of 
SAH, his emotion is unstable, which may cause the 
change of BP and lead to blood vessel rupture.  
The fatality rate of EHF is less than 5% nowa-
days, and if early diagnosis is made the fatality rate 
decreases8,  whereas  mortality  among  EHF  patients 
with  central  nervous  system  (CNS)  disturbance  is 
41%14. Despite the serious condition of SAH associ-
ated with EHF, the treatment is  mainly supportive. 
Careful fluid restriction and bed rest as well as seda-
tion  are  essential.  Control  of  body  temperature  is 
necessary  and  aspirin  or  cold  sponging  is  recom-
mended  for  high  fever8.  Ribavirin  increased  the 
number of survivors and the mean time to death in 
suckling mice infected with hantavirus, which signif-
icantly  reduced  mortality  in  patients  with  hemor-
rhagic  fever  with  renal  syndrome  in  China15.  An-
ti-hantavirus-neutralizing  monoclonal  antibodies  for 
treatment and prevention of hantavirus infection is an 
immunotherapy. Phase II clinical trials of this immu-
notherapy  for  emergent  treatment  of  patients  with 
hantavirus  infection  in  early  stages  of  hemorrhagic 
fever with renal syndrome are carried out in endemic 
areas in China16. To sum up, EHF patients with a se-
rious condition could have one or more CNS abnor-
malities,  such  as  sudden  headache  or  headache  ag-
gravated,  vomiting,  confusion,  meningismus,  and 
convulsions. Physicians need to consider the possibil-
ity of merging SAH, make further head CT and lum-
bar  puncture  or  DSA  examination,  and  give  timely 
treatment to improve the prognosis. 
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